Filed: 4/24/2023ACC: 0000950123-23-003359
📋 What this filing means
OUP MANAGEMENT CO., LLC filed this quarterly 13F‑HR report disclosing 14 equity positions with a total reported market value of $50.10M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
14
Positions
$50.10M
Total AUM (reported)
11.88M
Total Shares
Allocation by class
COMMON STOCK$38.80M77.4%
SPONSORED ADS$11.31M22.6%
Portfolio Concentration
Top 3$31.18M62.2%
4–10$17.29M34.5%
11–25$1.64M3.3%
Top 3 weight
62.2%
Top 10 weight
96.7%
Voting Authority Distribution
Total shares with voting rights: 11.88M
Sole
Full voting authority
11.88M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole14
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings14
Rows:
Aerovate Therapeutics Inc.
SOLEShares603.76K
TypeSH
Market value$12.18M
24.30%
Sole
603.76K
Shared
0.00
None
0.00
Centessa Pharmaceuticals plc
SOLEShares2.94M
TypeSH
Market value$11.31M
22.57%
Sole
2.94M
Shared
0.00
None
0.00
DICE Therapeutics Inc.
SOLEShares268.35K
TypeSH
Market value$7.69M
15.34%
Sole
268.35K
Shared
0.00
None
0.00
PMV Pharmaceuticals, Inc.
SOLEShares989.23K
TypeSH
Market value$4.72M
9.42%
Sole
989.23K
Shared
0.00
None
0.00
Cyteir Therapeutics, Inc.
SOLEShares2.46M
TypeSH
Market value$4.48M
8.93%
Sole
2.46M
Shared
0.00
None
0.00
ionQ, Inc.
SOLEShares389.67K
TypeSH
Market value$2.40M
4.78%
Sole
389.67K
Shared
0.00
None
0.00
Vor Biopharma Inc.
SOLEShares374.71K
TypeSH
Market value$2.02M
4.02%
Sole
374.71K
Shared
0.00
None
0.00
Prime Medicine, Inc.
SOLEShares121.25K
TypeSH
Market value$1.49M
2.98%
Sole
121.25K
Shared
0.00
None
0.00
Selecta Biosciences, Inc.
SOLEShares862.54K
TypeSH
Market value$1.20M
2.39%
Sole
862.54K
Shared
0.00
None
0.00
Graphite Bio
SOLEShares406.31K
TypeSH
Market value$995.5K
1.99%
Sole
406.31K
Shared
0.00
None
0.00
Precision BioSciences, Inc.
SOLEShares1.12M
TypeSH
Market value$847.0K
1.69%
Sole
1.12M
Shared
0.00
None
0.00
eFFECTOR Therapeutics, Inc.
SOLEShares1.03M
TypeSH
Market value$361.8K
0.72%
Sole
1.03M
Shared
0.00
None
0.00
Spero Therapeutics, Inc.
SOLEShares249.07K
TypeSH
Market value$361.2K
0.72%
Sole
249.07K
Shared
0.00
None
0.00
Homology Medicines, Inc.
SOLEShares64K
TypeSH
Market value$65.9K
0.13%
Sole
64K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Aerovate Therapeutics Inc.SOLE | Common Stock | 603.76K | SH | $12.18M 24.30% | 603.76K | 0.00 | 0.00 |
Centessa Pharmaceuticals plcSOLE | Sponsored ADS | 2.94M | SH | $11.31M 22.57% | 2.94M | 0.00 | 0.00 |
DICE Therapeutics Inc.SOLE | Common Stock | 268.35K | SH | $7.69M 15.34% | 268.35K | 0.00 | 0.00 |
PMV Pharmaceuticals, Inc.SOLE | Common Stock | 989.23K | SH | $4.72M 9.42% | 989.23K | 0.00 | 0.00 |
Cyteir Therapeutics, Inc.SOLE | Common Stock | 2.46M | SH | $4.48M 8.93% | 2.46M | 0.00 | 0.00 |
ionQ, Inc.SOLE | Common Stock | 389.67K | SH | $2.40M 4.78% | 389.67K | 0.00 | 0.00 |
Vor Biopharma Inc.SOLE | Common Stock | 374.71K | SH | $2.02M 4.02% | 374.71K | 0.00 | 0.00 |
Prime Medicine, Inc.SOLE | Common Stock | 121.25K | SH | $1.49M 2.98% | 121.25K | 0.00 | 0.00 |
Selecta Biosciences, Inc.SOLE | Common Stock | 862.54K | SH | $1.20M 2.39% | 862.54K | 0.00 | 0.00 |
Graphite BioSOLE | Common Stock | 406.31K | SH | $995.5K 1.99% | 406.31K | 0.00 | 0.00 |
Precision BioSciences, Inc.SOLE | Common Stock | 1.12M | SH | $847.0K 1.69% | 1.12M | 0.00 | 0.00 |
eFFECTOR Therapeutics, Inc.SOLE | Common Stock | 1.03M | SH | $361.8K 0.72% | 1.03M | 0.00 | 0.00 |
Spero Therapeutics, Inc.SOLE | Common Stock | 249.07K | SH | $361.2K 0.72% | 249.07K | 0.00 | 0.00 |
Homology Medicines, Inc.SOLE | Common Stock | 64K | SH | $65.9K 0.13% | 64K | 0.00 | 0.00 |